Clin2
NCT07398469Likely a fitRecruiting

Long-term study of zuranolone for postpartum depression symptoms

Postpartum Depression

Treatments studied

Part of Mental health, Women’s health & pregnancy clinical trials.

This study checks how people with postpartum depression feel over time after starting zuranolone. It uses simple questionnaires to track changes in symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have a prescription for zuranolone from Accredo Specialty Pharmacy.
  • You gave birth or had a pregnancy in the last 12 months.
  • You have been diagnosed with postpartum depression.
  • You can fill out questionnaires in English by yourself.
  • You haven't taken zuranolone or brexanolone in the past 12 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04685148Recruiting· Phase 1/Phase 2
Study of mental health treatment during pregnancy

This trial studies a treatment aimed at improving maternal mental health during pregnancy. It focuses on people who have had depression around pregnancy before, and checks whether the approach is safe and helpful for them.

Copenhagen
NCT05676918Recruiting
Postpartum well-being study for mothers in the past year

This study looks at mothers’ well-being after having a baby, to understand what affects mental and emotional health after childbirth. It may help improve support for mothers during the postnatal period.

Madrid, Pozuelo de Alarcón
NCT05700760Recruiting
ROSE program study to prevent postpartum depression

This study tests whether a program called ROSE can help prevent postpartum depression after delivery. If you’re pregnant, you may be asked to complete questionnaires and be reached by phone for study steps.

Flint, Michigan
NCT06238700Recruiting
Studying allopregnanolone for depression in midlife women

This trial tests whether allopregnanolone, a natural brain chemical, can help depression in women going through menopause. It compares the effects against a placebo to see if it improves mood symptoms.

Boston, Massachusetts
NCT06759558Recruiting· Phase 2
Zuranolone for post-stroke depression

This trial tests a new medicine called zuranolone (allopregnanolone) for people with depression after a stroke. It aims to see if the drug can help improve mood when taken over a short period.

Durham, North Carolina
NCT07822321Recruiting· Phase 3
Brexanolone for severe postpartum depression

This trial tests an investigational medicine to help mothers with severe depression that started late in pregnancy or shortly after childbirth. It aims to improve mood and overall well-being.

Tucson, Arizona

Hear when a new Postpartum Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.